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Letters to the Editorthe long-term survival of patients
undergoing pulmonary resection after
TEMLA have never been published.
The transcervical approach to the
mediastinum is fascinating indeed.
Its applications warrant investigation
in well-designed clinical trials and, if
justified by these trials, implementa-
tion into routine practice. We should
not, however, allow our fascination
to blur our objectivity and clear vision
of all aspects of the matter. Safety of
our patients is certainly a priority.
Jarosław Ku_zd_zał, MD, PhD
Zbigniew Grochowski, MD, PhD
Janusz Warmus, MD, PhD
Department of Thoracic Surgery
Jagiellonian University Collegium
Medicum
John Paul II Hospital
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Weappreciate the interest in our arti-
cle demonstrated by Ku _zd _za1 and col-
leagues. In response, we would like to
draw their attention to several facts.
First, in our article we clearly stated
that transcervical extended mediastinal
lymphadenectomy(TEMLA)andvideo-
assisted mediastinal lymphadenec-
tomy (VAMLA) are more invasive
than mediastinoscopy or endobron-
chial ultrasonography and therefore
should only be considered in specific1150 The Journal of Thoracic andsituations. Such circumstances gener-
ally involve the suspicion of N2 or N3
involvement not detected by imaging,
particularly when the detection of
such disease would change surgical
options. Therefore Ku _zd _za1 and col-
leagues’ call for safety is echoed by
us as well.
Second, most TEMLA and
VAMLA reports are from a few select
centers. The safety of these proce-
dures should be replicated by many
other centers before the techniques
are accepted by the surgical commu-
nity at large. This point was made in
our article multiple times.
Third, several statistics are quoted
by Ku _zd _za1 and colleagues that point
out potential downsides of TEMLA.
For example, the overall high rate of
morbidity is quoted from their refer-
ences, but the highest proportion of
morbidity is a widened mediastinum,
which is of doubtful functional
significance.1,2 The 1.2% mortality
from TEMLA that they mentioned
also seems erroneous, as the reference
cited clearly states that the mortality
was not related to the procedure itself.
Ku_zd _za1 and colleagues also mention
isolated instances of injury to
mediastinal structures; however, this
is a well-known complication of medi-
astinal surgery in general, and such in-
stances have been reported with
mediastinoscopy as well.3 Of the vari-
ous complications noted in the commu-
nication of Ku _zd _za1 and colleagues,
perhaps the most concerning is the
statement that 21% of patients become
unfit for further surgerysolelyasa result
of TEMLA; however, this seems to be
their inference rather than a result de-
clared in the articles they referenced.
Contrary to this inference, the final cita-
tion included in their letter (a 2010anal-
ysis of 587 TEMLA patients) reported
a 6.8% complication rate, with 2.1%
major enough to limit subsequent thora-
cotomy, anda15% aggregateTEMLA-
negative nonthoracotomy rate. This
15% (not 21%) contains some patients
unfit for thoracotomy who underwent
surgical staging for better treatmentCardiovascular Surgery c April 2013planning (nonthoracotomy rates ap-
proach 10% in mediastinoscopy se-
ries). Intuitively, enhanced TEMLA
and VAMLA dissections should be
a bit more prone to complications than
mediastinoscopy when performed as
isolated procedures.Whenwe integrate
themwith video-assisted thoracoscopic
surgery or thoracotomy under the same
anesthetic, however, we just observe
a different surgical approach for the
same mediastinal lymph node dissec-
tion and do not expect substantial addi-
tional morbidity. Finally it is important
to note that TEMLA and VAMLA use
most of the safe exposure techniques
from well-validated procedures such
as mediastinoscopy and transcervical
thymectomy.
Therefore, although we agree that
TEMLA and VAMLA deserve further
study in multiple centers to assess
generalizability of safety and lymph
node yield, we do not see anything in
the current literature that raises safety
concerns to the extent interpreted by
Ku _zd _za1 and colleagues. If such data
exist, they ought to be published.
Certainly in our unpublished experi-
ence with more than 100 (mostly post-
induction) patients, we have not seen
any sign of prohibitive morbidity. It
is uncertain whether new surgical
approaches such as these will be
evaluated by adequately powered
randomized clinical trials. Until they
are, our surgical community will
have to judge their utility by thought-
fully interpreting retrospective
studies.
Sai Yendamuri, MBBS
Todd L. Demmy, MD, FACS
Department of Thoracic Surgery
Roswell Park Cancer Institute
Buffalo, NY
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THORACOSCOPIC
ULTRASONOGRAPHY REALLY
NEEDED FOR EVERY
INTRAPARENCHYMAL
PULMONARY NODULE?
To the Editor:
We read with interest the report by
Khereba and colleagues,1 ‘‘Thoraco-
scopic localization of intraparenchy-
mal pulmonary nodules using direct
intracavitary thoracoscopic ultraso-
nography prevents conversion of
VATS procedures to thoracotomy in
selected patients,’’ which appeared in
the November issue of the Journal.
We congratulate Khereba and col-
leagues1 for their effort in clarifying
the usefulness of this technique in
practice of video-assisted thoraco-
scopic surgery (VATS) for localiza-
tion of intraparenchymal pulmonary
nodules; however, we want to share
some significant concerns we had as
we read their report.
Our first concern pertains to the in-
dications for ultrasonography in pa-
tients with indeterminate pulmonary
nodules. In the study of Khereba and
colleagues,1 27 nodules were found
not more than 1 cm distant from the
pleura on computed tomographic
scan. For these cases, we argue that
they didn’t really need ultrasonogra-
phy to find a lesion just beneath the
pleura, because direct visualization,
palpation byfinger, or a slidingmethod
with an instrument might be helpful in
localization of the target nodule, and
most cases did not require any type of
special localization method.2
Second, in 1 case there was an
unidentifiable nodule with high proba-
bility of malignancy, and a thoraco-
scopic lobectomy was performed
directly. Of course, thoracoscopicThe Journallobectomy is a standard procedure
for unidentifiable nodules with high
probability of malignancy.3 A thora-
coscopic segmentectomy is also en-
couraging with curative purpose,
because survival after thoracoscopic
segmentectomy for small peripheral
non–small cell lung cancer (2 cm)
has been reported to be comparable
to that after thoracoscopic lobec-
tomy.4 In our practice, we have found
direct segmentectomy to be an alter-
native method for management of
those small and indeterminate periph-
eral pulmonary nodules, without the
need to identify the precise location
of the nodules by ultrasonography.
Third, Khereba and colleagues1
concluded that VATS ultrasonography
prevented conversion to thoracotomy
or lobectomy without tissue diagnosis
in 43.5% of cases (20/46). We argue
that if precise location of the target
nodule could not be confirmed, would
the 20 cases all have needed to be con-
verted to thoracotomy or lobectomy?
In our practice of dealing with those
so called ‘‘unidentifiable nodules,’’
we haven’t seen such a high conver-
sion rate. Furthermore, even in the
practice of lobectomy by VATS, the
conversion rate was only 2.66%
(11/414) in our group.5
We do agree with Khereba and col-
leagues1 that intracavitary thoraco-
scopic ultrasonography could locate
intrapulmonary nodules with high
sensitivity and specificity. We believe,
however, that just because intracavi-
tary thoracoscopic ultrasonography is
useful does not mean that it should
be done in every case. The practical
value of VATS ultrasonography ap-
pears excessively amplified.
Chengwu Liu, MD
Qiang Pu, MD
Lunxu Liu, MD, PhD
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West China Hospital
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In our study, patients were recruited
on the basis of the attending general
thoracic surgeon’s impression of diffi-
culty in finding the nodules on reading
the preoperative computed tomo-
graphic scan. Indeed, there were nod-
ules not more than 1 cm from the
visceral pleura; however, these nod-
ules were chosen because of their
small size or nonsolid nature (ground
glass). Patients who had nodules that
were believed to be easily found on
thoracoscopy were not enrolled in
the trial. In fact, a large proportion of
video-assisted thoracoscopic surgical
(VATS) wedge procedures performed
during the study period were per-
formed without the use of ultrasonog-
raphy. We agree with the statement in
the letter that ‘‘just because intracavi-
tary ultrasonography is useful does
not mean that it should be done in ev-
ery case.’’ We do not perform VATS
with ultrasonography in all cases,
only when we cannot find the nodule
with standard techniques.y c Volume 145, Number 4 1151
